I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Liu, Shaochuan
157
results:
Search for persons
X
Format
Online (157)
Mediatypes
Articles (Online) (71)
Bookchapter (Online) (13)
OpenAccess-fulltext (73)
Sorted by: Relevance
Sorted by: Year
?
1
Phosphoglycerate mutase 1 promotes breast cancer progressio..:
Zhang, Dong
;
Wang, Min
;
Ma, Shiya
...
Cancer Gene Therapy. 31 (2024) 7 - p. 1018-1033 , 2024
Link:
https://doi.org/10.1038/..
?
2
Multiomics profiling reveals the benefits of gamma-delta (γ..:
Li, Junyi
;
Cao, Yuanjie
;
Liu, Yancheng
...
Journal for ImmunoTherapy of Cancer. 12 (2024) 1 - p. e008355 , 2024
Link:
https://doi.org/10.1136/..
?
3
Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for..:
Lv, Yingge
;
Zhao, Hua
;
Liu, Shaochuan
...
Journal of Leukocyte Biology. , 2024
Link:
https://doi.org/10.1093/..
?
4
Immune‐independent acquired resistance to PD‐L1 antibody in..:
Gao, Yuan
;
Feng, Yingfang
;
Liu, Shaochuan
...
Cancer Medicine. 12 (2023) 14 - p. 15337-15349 , 2023
Link:
https://doi.org/10.1002/..
?
5
Novel strategies for cancer immunotherapy: counter-immunoed..:
Liu, Shaochuan
;
Sun, Qian
;
Ren, Xiubao
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
6
CD4+ T cells are required to improve the efficacy of CIK th..:
Liu, Shaochuan
;
Meng, Yuan
;
Liu, Liang
...
Cell Death & Disease. 13 (2022) 5 - p. , 2022
Link:
https://doi.org/10.1038/..
?
7
Rational pemetrexed combined with CIK therapy plus anti-PD-..:
Liu, Shaochuan
;
Meng, Yuan
;
Liu, Liang
...
Cancer Gene Therapy. 30 (2022) 2 - p. 277-287 , 2022
Link:
https://doi.org/10.1038/..
?
8
Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab:
Liu, Zhujun
;
Qin, Tingting
;
Yuan, Xiaohan
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
9
Molecular subtypes based on CNVs related gene signatures id..:
Li, Baihui
;
Huang, Ziqi
;
Yu, Wenwen
...
Neoplasia. 23 (2021) 7 - p. 704-717 , 2021
Link:
https://doi.org/10.1016/..
?
10
Clinical importance of VEGFC and PD‐L1 co‐expression in lun..:
Qin, Tingting
;
Xia, Junling
;
Liu, Shaochuan
...
Thoracic Cancer. 11 (2020) 5 - p. 1139-1148 , 2020
Link:
https://doi.org/10.1111/..
?
11
anlotinib alters tumor immune microenvironment by downregul..:
Liu, Shaochuan
;
Qin, Tingting
;
Liu, Zhujun
...
Cell Death & Disease. 11 (2020) 5 - p. , 2020
Link:
https://doi.org/10.1038/..
?
12
PD-L1 Expression Is Associated With VEGFA and LADC Patients..:
Liu, Shaochuan
;
Qin, Tingting
;
Jia, Yanan
.
Frontiers in Oncology. 9 (2019) - p. , 2019
Link:
https://doi.org/10.3389/..
?
13
Multiomics profiling reveals the benefits of gamma-delta (γ..:
Li, Junyi
;
Cao, Yuanjie
;
Liu, Yancheng
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10806547/. , 2024
Link:
http://www.ncbi.nlm.nih...
?
14
CD4(+) T cells are required to improve the efficacy of CIK ..:
Liu, Shaochuan
;
Meng, Yuan
;
Liu, Liang
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076680/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab:
Liu, Zhujun
;
Qin, Tingting
;
Yuan, Xiaohan
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158131/. , 2022
Link:
http://www.ncbi.nlm.nih...
1-15